These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 1639161)

  • 1. Plasmodium falciparum: induction of biologically active antibodies to gp195 is dependent on the choice of adjuvants.
    Hui GS; Chang SP
    Exp Parasitol; 1992 Aug; 75(1):155-7. PubMed ID: 1639161
    [No Abstract]   [Full Text] [Related]  

  • 2. Influence of adjuvants on the antibody specificity to the Plasmodium falciparum major merozoite surface protein, gp195.
    Hui GS; Chang SP; Gibson H; Hashimoto A; Hashiro C; Barr PJ; Kotani S
    J Immunol; 1991 Dec; 147(11):3935-41. PubMed ID: 1940375
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Reduction of disulfide bonds in Plasmodium falciparum gp195 abolishes the production of growth-inhibitory antibodies.
    Locher CP; Tam LQ
    Vaccine; 1993; 11(11):1119-23. PubMed ID: 8249430
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Immunogenicity of a hybrid Plasmodium falciparum malaria antigen.
    Lockyer MJ; Cooper H; Tite J; Rowan W; Crowe JS
    Parasitology; 1993 Jun; 106 ( Pt 5)():451-7. PubMed ID: 8341580
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A carboxyl-terminal fragment of Plasmodium falciparum gp195 expressed by a recombinant baculovirus induces antibodies that completely inhibit parasite growth.
    Chang SP; Gibson HL; Lee-Ng CT; Barr PJ; Hui GS
    J Immunol; 1992 Jul; 149(2):548-55. PubMed ID: 1624802
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Synthetic low-toxicity muramyl dipeptide and monophosphoryl lipid A replace Freund complete adjuvant in inducing growth-inhibitory antibodies to the Plasmodium falciparum major merozoite surface protein, gp195.
    Hui GS; Tam LQ; Chang SP; Case SE; Hashiro C; Siddiqui WA; Shiba T; Kusumoto S; Kotani S
    Infect Immun; 1991 May; 59(5):1585-91. PubMed ID: 2019429
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Intraerythrocytic administration of a synthetic Plasmodium antigen elicits antibody response in mice, without carrier molecules or adjuvants.
    Esposito F; Santroni AM; Habluetzel A; Grelloni V; Pessi A; Lombardi S; Falcioni G; Brunori M
    Int J Parasitol; 1990 Dec; 20(8):1109-11. PubMed ID: 2074141
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Immunogenicity and efficacy trials in Aotus nancymai monkeys with model compounds representing parts of a 75-kD merozoite surface antigen of Plasmodium falciparum.
    Sharma P; Ruebush TK; Campbell GH; Richman SJ; Wilkins PP; Broderson JR; Ardeshir F; Gross M; Silverman C; Skinner JC
    Am J Trop Med Hyg; 1992 Jun; 46(6):691-707. PubMed ID: 1621894
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Proteosome-hydrophobic 'foot' malaria peptide vaccines for Plasmodium falciparum and P. vivax.
    Lowell GH; Ballou WR; Smith LF; Zollinger WD; Hockmeyer WT
    Trans R Soc Trop Med Hyg; 1989; 83 Suppl():101-2. PubMed ID: 2696152
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Overcoming inhibition of antibody responses to a malaria recombinant vaccinia virus caused by prior exposure to wild type virus.
    Etlinger HM; Altenburger W
    Vaccine; 1991 Jul; 9(7):470-2. PubMed ID: 1716807
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Lipopeptide immunization without adjuvant induces potent and long-lasting B, T helper, and cytotoxic T lymphocyte responses against a malaria liver stage antigen in mice and chimpanzees.
    BenMohamed L; Gras-Masse H; Tartar A; Daubersies P; Brahimi K; Bossus M; Thomas A; Druilhe P
    Eur J Immunol; 1997 May; 27(5):1242-53. PubMed ID: 9174617
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Muramyl peptide adjuvants for Plasmodium falciparum and Plasmodium vivax circumsporozoite vaccines in rodent model systems.
    Bathurst IC; Gibson HL; Kansopon J; Hahm BK; Hollingdale MR; Barr PJ
    Biotechnol Ther; 1992; 3(1-2):15-34. PubMed ID: 1305890
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Immunogenicity of the Plasmodium falciparum asexual blood-stage synthetic peptide vaccine SPf66.
    Millet P; Campbell GH; Sulzer AJ; Grady KK; Pohl J; Aikawa M; Collins WE
    Am J Trop Med Hyg; 1993 Mar; 48(3):424-31. PubMed ID: 7682382
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Sporozoite malaria vaccine. Where do we stand?
    Nussenzweig V; Nussenzweig S
    Ann Parasitol Hum Comp; 1990; 65 Suppl 1():49-52. PubMed ID: 1702271
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Fine specificity of immune responses to epitopic sequences in synthetic peptides containing B and T epitopes from the conserved Plasmodium falciparum blood-stage antigens.
    Chatterjee S; Sharma P; Kumar S; Chauhan VS
    Vaccine; 1995; 13(15):1474-81. PubMed ID: 8578829
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antibodies to the major merozoite surface coat protein of Plasmodium falciparum (gp195) in a human population living in a malaria-endemic area of the Philippines.
    Kramer KJ; Oberst R
    Am J Trop Med Hyg; 1992 Oct; 47(4):429-39. PubMed ID: 1443339
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Current state of the studies of malaria vaccine].
    Dzbeński TH
    Przegl Epidemiol; 1990; 44(3):173-8. PubMed ID: 2084799
    [No Abstract]   [Full Text] [Related]  

  • 18. Expression systems that best mimic native structure: which ones to try first and why.
    Chang SP
    Am J Trop Med Hyg; 1994; 50(4 Suppl):11-9. PubMed ID: 7513505
    [No Abstract]   [Full Text] [Related]  

  • 19. Plasmodium falciparum: gp195 tripeptide repeat-specific monoclonal antibody inhibits parasite growth in vitro.
    Locher CP; Tam LQ; Chang SP; McBride JS; Siddiqui WA
    Exp Parasitol; 1996 Oct; 84(1):74-83. PubMed ID: 8888734
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Conserved polypeptides of Plasmodium falciparum as malaria vaccine candidates?
    Herrera S; Herrera MA; Clavijo C; Corredor A; Certa U
    Acta Leiden; 1991; 60(1):107-10. PubMed ID: 1820697
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.